REFERENCES
- Davis NVB, Taylor JA, Oakes JE. Ocular infection with herpes simplex virus type I: prevention of acute herpetic encephalitis by systemic administration of virus-specific anti-body. J Infect Dis 1979; 140: 534–540.
- Narang HK. Mechanism of demyelination after HSV type 1 intraocular injection in rabbits. J Neurol Sci 1980; 45: 109–122.
- Narang HK. Efficacy of herpes vaccine in a rabbit model following intraocular inoculation of herpes simplex virus. J Infect Dis 1984; 149: 973–979.
- Narang HK, Codd AA. The pathogenesis and pathway into central nervous system after intraocular injection of her-pes simplex virus type 1 in rabbit. Neuropath Appl Neurobiol 1978; 4: 137–150.
- Narang HK, Codd AA. Progression of herpes encephali-tis in rabbits following the intraocular injection of type 1 virus. Neuropath Appl Neurobiol 1978; 4: 457–470.
- Centifanto YM, Little JM, Kaufman HE. The relation-ship between virus chemotherapy, secretory antibody forma-tion and recurrent herpetic disease. Ann N Y Acad Sci 1970; 173: 649–656.
- Wheeler CE Jr. Pathogenesis of recurrent herpes sim-plex infections . J Invest Dermatol 1975; 65: 341–346.
- Rager-Zisman B, Allison AC. Mechanism of immunolog-ic resistance to herpes simplex virus type I (HSV-I) infec-tions. J Immunol 1976; 116: 35–40.
- Ennis FA. Host defence mechanism against herpes sim-plex virus II Protection confirmed by sensitised spleen cells. J Infect Dis 1973; 127: 632–638.
- Worthington M, Conliffe MA, Baron S. Mechanism of recovery from systemic herpes virus infection I: comparative effectiveness of antibody and reconstitution of immune spleen cells on immunosuppressed mice. J Infect Dis 1980; 142: 163–174.
- Gilden DH, Cole GA, Nathanson M. Fatal central ner-vous system (CNS) disease in lymphocytic choriomeningitis (LCM) virus carrier mice given LCM-immune donor spleen cells. Fed Proc 1971; 30: A353.